What Is Alpha-Lipoic Acid and Why Does Dosage Matter?
Alpha-lipoic acid (ALA) is a sulphur-containing compound that functions as a cofactor in mitochondrial enzyme complexes involved in energy metabolism. Unlike some antioxidants that work only in water-soluble or fat-soluble environments, ALA is active in both compartments, giving it broad tissue access. The body produces small amounts endogenously, but supplemental doses are substantially higher than what food and endogenous synthesis provide.
ALA supplementation has been studied across a range of doses from around 100 mg to over 1800 mg daily, with different dose windows used for different goals. Getting the dose right matters because ALA has a narrow therapeutic window in some contexts and because higher doses increase the risk of side effects.
Studied Effective Dose Ranges
The clinical evidence base for ALA spans several areas:
Glycaemic control and insulin sensitivity: Multiple RCTs have used doses of 600 mg/day. A meta-analysis of randomised controlled trials found that ALA supplementation was associated with significant reductions in fasting blood glucose and insulin resistance markers (Akbari et al., 2018). The 600 mg dose was the most consistently studied.
Diabetic neuropathy: The most robust evidence for ALA comes from intravenous and oral ALA in peripheral diabetic neuropathy. Oral doses studied range from 600 mg to 1800 mg daily, with the 600 mg three-times-daily protocol showing improvements in neuropathic symptom scores in the ALADIN III trial (Ziegler et al., 1999). This is a clinical application, not a sports nutrition context.
Antioxidant effects in healthy people: Lower doses in the range of 100–300 mg/day appear sufficient to elevate plasma ALA concentrations and enhance glutathione recycling, though clinical outcome data at these doses are limited.
Dose by Goal
| Goal | Common Studied Dose | Evidence Quality |
|---|---|---|
| Glycaemic support | 600 mg/day | Moderate (RCTs, meta-analysis) |
| Neuropathy (clinical use) | 600–1800 mg/day | Moderate–high (multiple RCTs) |
| General antioxidant support | 100–300 mg/day | Low–moderate (mechanistic) |
Body weight has not been shown to be a reliable dosing determinant for ALA in the available literature — flat dosing protocols are standard in all trials.
Upper Limits and EFSA Position
EFSA reviewed ALA safety and did not set a tolerable upper intake level (UL) due to insufficient data. The European Food Safety Authority noted that doses up to 600 mg/day appear safe for healthy adults based on available evidence, but acknowledged that long-term safety data above this dose are limited.
At doses above 1200 mg/day, gastrointestinal side effects (nausea, vomiting, stomach cramps) become more common. There are isolated case reports of hypoglycaemia in diabetic patients on insulin or sulphonylureas taking high-dose ALA — this is relevant if combining ALA with glucose-lowering medications.
For healthy sports nutrition users without glycaemic conditions, a dose of 300–600 mg/day represents a reasonable balance of evidence and precaution.
Timing Relative to Dose
ALA is best absorbed when taken on an empty stomach, as food — particularly high-fat meals — can reduce the speed and extent of absorption. A practical approach is to take ALA at least 30 minutes before a meal. If GI discomfort occurs on an empty stomach, taking it with a light, low-fat snack is an acceptable compromise.
R-ALA (the R-enantiomer, the biologically active form) has higher bioavailability per mg than racemic ALA (the commercially standard 50:50 mixture of R and S forms). If comparing products, note that some label their product as R-ALA to signal the purer active form.
Practical Protocol
For healthy adults seeking antioxidant support:
- Dose: 300–600 mg/day
- Form: R-ALA or racemic ALA (standard)
- Timing: 30 minutes before the largest meal, or on an empty stomach
- Cycling: There is no established cycling protocol; consistent daily use for 8–12 weeks is typical in trials
- Stacking: ALA is often combined with B vitamins (for mitochondrial support) and is complementary to CoQ10 in that context
Alpha-lipoic acid supplements are available at maxfit.ee/et/category/alfalipoehape-ala.
References
Akbari, M., Ostadmohammadi, V., Lankarani, K. B., Tabrizi, R., Kolahdooz, F., Khatibi, S. R., & Asemi, Z. (2018). The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Metabolism, 87, 56–69. PMID: 29800686 https://pubmed.ncbi.nlm.nih.gov/29990473/
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Hasche, H., Lobisch, M., Schütte, K., … Gries, F. A. (1999). Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). Diabetes Care, 22(8), 1296–1301. PMID: 10480771 https://pubmed.ncbi.nlm.nih.gov/10480774/
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009). Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta, 1790(10), 1149–1160. PMID: 19664690 https://pubmed.ncbi.nlm.nih.gov/19664690/
FAQ
Can I take alpha-lipoic acid every day?
Yes. Daily use is the standard protocol in all clinical trials. There is no established evidence requiring cycling. For general antioxidant support in healthy adults, consistent daily use over weeks to months is how most studies are designed.
Does ALA interact with thyroid medication?
There is evidence from animal studies suggesting that high-dose ALA may interfere with thyroid hormone function, and limited case reports in humans. People on thyroid hormone replacement (e.g., levothyroxine) should separate ALA supplementation by at least 4 hours from their thyroid medication and consult their prescribing physician.
What is the difference between R-ALA and regular ALA?
Commercial ALA is typically a racemic (50:50) mixture of the R and S enantiomers. The R form is the biologically active form naturally produced in the body. R-ALA has greater bioavailability than the racemate, meaning a lower absolute dose of R-ALA may achieve similar plasma levels to a higher dose of standard ALA. R-ALA supplements typically cost more and may require lower doses to achieve the same effect.
